GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...

ABL Bio Inc. sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier penetrating bispecific antibody platform, ...

Eugene Greening, Green Bay Packers super fan known as Mean Gene, the Dancing Machine, died Saturday at age 80. As his super fan name describes, Greening was known for breaking out in dance around ...

Patient was a 16-year-old teen, who underwent treatment in Dec First death reported after Elevidys treatment Liver injury a known risk with gene therapies March 18 (Reuters) - Sarepta Therapeutics ...

It's been nearly three years since controversial Chinese biophysicist He Jiankui was released from prison for gene-hacking human babies — and now, he appears to be hitting back at the rules ...

Inherited repeat mutations in the HTT gene expand in neurons over decades before crossing a toxic threshold, revealing a long time window for therapy. CAG repeats in HTT are unstable, meaning that ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

The original Gene line-up have reunited and announced their first live show in over 20 years. Read NME‘s interview with frontman Martin Rossiter below, where he discusses what to expect from the ...

This swapping or “translocation” leads to the formation of a new gene, or oncogene, called BCR-ABL. This oncogene produces a protein called BCR-ABL protein, which causes CML cells to grow and ...